I often focus on Morgan Stanley's research as its research department is one of the more conservative out of the major brokerage houses (UBS is the worst, consistently bullish).
Anyway here is the summary:
Price target: $1.70
Yes thats right $1.70
David Jones earnings are rebasing following years
of cost out and underinvestment – this could be a
painful experience for investors, in our view. We
aren’t convinced it will be an online winner despite
its ambitions. We retain an Underweight rating.
EPS Estimates:
2012: 0.2
2013: 0.19
2014: 0.16
DPS:
2012: 0.17
2013: 0.16
2014: 0.14
Collectively the department stores are
embarking upon a strategy of
aggressive store rollout. We hold
concerns over the ability to do this
profitably as consumers spend more
online.
• Department stores are typically low
growth retailers that are a laggard of
retail trends.
• After years of cost out, reinvestment is
now occurring which is leading to a
rebasing of profits
• The internet is a real threat to
Australian-based high margin
retailers like DJS
David Jones significant profit warning highlights to us that cost
out has gone too far and exposes underinvestment in the
business over many years. We think that it will take years for
its earnings to rebase – so we cannot recommend its shares.
While we like its initiatives to invest in service and the online
channel, realistically, it will be some time before this
investment bears fruit. To us online ‘winners’ tend to be
retailers that own brands, rather than just distribute product,
so we can’t see DJS executing a value enhancing strategy
online. The company has also given its competitors (huge
global players) a significant head start and the capital
investment budget for online does not look to be enough.
Valuation looks stretched as stable financial services profits
collapse to put the stock on an F2014 P/E of 15x, the most
expensive in the sector. We retain an UW rating.
- Forums
- ASX - By Stock
- DJS
- morgan stanley update on djs
morgan stanley update on djs
Featured News
Add DJS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online